Abstract
A 4-year-old Japanese girl received a continuous infusion of gabexate mesilate (200 mg/25 ml 5% glucose) for 6 days via a peripheral vein for the treatment of hemolytic uremic syndrome. After administration, pigmentation was seen at the needle entry point on her right hand. Six years later, an elastic, hard subcutaneous mass was noted around this pigmentation. The tumor was encapsulated and partially adherent to the tendon of the extensor digitorum muscle. Histological examination revealed a membranous structure consisting of fibrous tissue containing many inflammatory cells. This was considered to be a side effect of gabexate mesilate.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
